Form 4: EverQuote CEO Jayme Mendal Sells 14,360 Shares of Class A Common Stock
SEC Form 4 Filing
EverQuote's CEO, Jayme Mendal, sold 14,360 shares of Class A Common Stock at an average price of $23.54 on May 20, 2025, according to a Form 4 filing with the SEC.
Summary
- On May 20, 2025, Jayme Mendal, the CEO and President of EverQuote, Inc., sold 14,360 shares of Class A Common Stock.
- The sale was executed at a weighted average price of $23.54 per share.
- The transactions occurred at prices ranging from $23.32 to $23.98.
- Following the reported transaction, Mendal directly owns 573,149 shares of EverQuote's Class A Common Stock.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on December 17, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting an insider stock sale. It doesn't inherently convey positive or negative sentiment, as it's a factual disclosure.
Industry Context
This filing is a routine disclosure of insider trading activity. It's common for executives to sell shares under pre-arranged trading plans to diversify their holdings or for personal financial planning.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholder sentiment, but the pre-arranged nature of the sale under a 10b5-1 plan mitigates potential concerns.
Key Dates
| Date | Description |
|---|---|
| 12/17/2024 | Date of adoption of Rule 10b5-1 trading plan |
| 05/20/2025 | Date of stock sale transaction |
| 05/22/2025 | Date of Form 4 filing |
Keywords
Form 4, SEC Filing, Jayme Mendal, EverQuote, Stock Sale, Class A Common Stock, Rule 10b5-1, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.